Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

Edema, or fluid retention, does not always require treatment. However, a doctor will address any underlying causes and may prescribe medications such as furosemide or heparin to reduce fluids in ...

Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...

Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...

The Food and Drug Administration (FDA) has expanded the approval of Furoscix® (furosemide injection) to include the treatment of edema in patients with ...

Racial and ethnic minorities are underrepresented in DRCRnet DME trials, despite experiencing more severe symptoms than other ...

Furosemide injection was previously approved to treat congestion from fluid buildup in adults with chronic heart failure.

Secondary endpoints will evaluate the magnitude of macula edema reduction, improvement in visual acuity and the systemic pharmacokinetic profile of KIO-104. The study will enroll patients with ...

The following is a summary of “Racial and Ethnic Disparities at Enrollment in DRCRnet Clinical Trials for Diabetic Macular ...